Target Group Inc. (CBDY)

USD 0.0

(28.57%)

Market Cap (In USD)

1.11 Million

Revenue (In USD)

3.72 Million

Net Income (In USD)

-323.67 Thousand

Avg. Volume

351.24 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.0012-0.0084
PE
-
EPS
-
Beta Value
0.552
ISIN
US87614W1045
CUSIP
87614W104
CIK
1586554
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Anthony Carlo Zarcone
Employee Count
-
Website
https://www.targetgroupinc.ca
Ipo Date
2015-12-28
Details
Target Group Inc. cultivates, processes, and distributes curated cannabis products for the adult-use medical and recreational cannabis market in Canada. Its products include cannabis flower and extract pods for vaporizer use, cannabis pre-rolls, k-cup infused coffee and tea pods, infused cannabis beverages and edibles, infused topical products, and CBD wellness products. The company also offers Wisp, a single-use pre-measured pod and vaporizer system for consumers involved in vaporizing natural herbs, including cannabis. It has a collaboration agreement with cGreen, Inc for manufacturing and distributing the patent-pending THC antidote True Focus in the United States, Europe, and the Caribbean; and distribution, collaboration, and licensing agreement with Serious Seeds B.V. The company was formerly known as Chess Supersite Corporation and changed its name to Target Group Inc. in July 2018. The company was incorporated in 2013 and is based in Hamilton, Canada.